DEC-C Post-Transplant

A Phase I/II Trial of Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

Arms / Cohorts

Experimental:Phase 1 Dose Level 1: DEC-C

Accepting patients

Experimental:Phase 1 Dose Level 2: DEC-C

Accepting patients

Experimental:Phase 2 MRD Positive: DEC-C

Accepting patients

Observational, Active Comparator Arm:Phase 2: MRD Negative

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.